在女性健康倡议队列中使用多基因遗传风险评分预测黑色素瘤风险
研究利用21个全基因组关联研究显著的单核苷酸多态性(SNP)计算遗传风险评分,在19,102名绝经后白人女性中评估其与黑色素瘤发生的关联。相比遗传风险最低三分位组,最高三分位组发生黑色素瘤的可能性为1.9倍(95%CI 1.50-2.42);将遗传风险评分加入年龄后, incident黑色素瘤的c-index增量为0.075(95%CI 0.041-0.109)。结论认为较高的遗传风险与绝经后女性黑色素瘤患病率和发病率增加相关,但当表型信息可用时,当前遗传信息在风险预测中作用可能有限。
要点
- 在19,102名绝经后白人女性中,最高遗传风险三分位组发生黑色素瘤的可能性是最低三分位组的1.9倍。
- 将遗传风险评分加入年龄后,incident黑色素瘤的c-index增量为0.075(95%CI 0.041-0.109)。
- 当前遗传信息在表型信息可用时对风险预测的作用可能有限。
核心结论
- 较高的遗传风险与绝经后女性黑色素瘤患病率和发病率增加相关。
- 当表型信息可用时,当前遗传信息在风险预测中可能作用有限。
研究设计与样本
- 研究使用21个全基因组关联研究显著的单核苷酸多态性(SNP)计算遗传风险评分。
- 在女性健康倡议(Women's Health Initiative)数据集的临床试验和观察性研究组中,对19,102名绝经后白人女性评估了遗传风险评分对黑色素瘤发生的联合效应。
主要发现
- 相比加权遗传风险评分最低三分位组,最高三分位组女性发生黑色素瘤的可能性为1.9倍(95%置信区间1.50-2.42)。
- 将遗传风险评分加入年龄后,incident黑色素瘤的c-index增量为0.075(95%置信区间0.041-0.109)。
局限性
- 缺乏痣计数、Fitzpatrick皮肤类型和黑色素瘤家族史的信息。
- 女性健康倡议队列中可能存在报告偏倚和选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-nucleotide polymorphisms (SNPs) associated with melanoma have been identified though genome-wide association studies. However, the combined impact of these SNPs on melanoma development remains unclear, particularly in postmenopausal women who carry a lower melanoma risk. OBJECTIVE: We examine the contribution of a combined polygenic risk score on melanoma development in postmenopausal women. METHODS: Genetic risk scores were calculated using 21 genome-wide association study-significant SNPs. Their combined effect on melanoma development was evaluated in 19,102 postmenopausal white women in the clinical trial and observational study arms of the Women's Health Initiative dataset. RESULTS: Compared to the tertile of weighted genetic risk score with the lowest genetic risk, the women in the tertile with the highest genetic risk were 1.9 times more likely to develop melanoma (95% confidence interval 1.50-2.42). The incremental change in c-index from adding genetic risk scores to age were 0.075 (95% confidence interval 0.041-0.109) for incident melanoma. LIMITATIONS: Limitations include a lack of information on nevi count, Fitzpatrick skin type, family history of melanoma, and potential reporting and selection bias in the Women's Health Initiative cohort. CONCLUSION: Higher genetic risk is associated with increased melanoma prevalence and incidence in postmenopausal women, but current genetic information may have a limited role in risk prediction when phenotypic information is available.
引用
- Cho HG, Ransohoff KJ, Yang L, et al. Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort. J Am Acad Dermatol. 2018. PMID: 29499294. doi:10.1016/j.jaad.2018.02.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。